Legend Capital’s portfolio company Xbiome Inc., an industry-leading and AI-driven microbiome therapeutics company, recently announced that it acquired the clinical-stage…
Browsing: BioTech
Legend Capital’s portfolio company Lunit, a Korean Medical AI company, recently announced a preliminary approval from the Korea Exchange for…
Shanghai Langsheng Biotechnology Co., Ltd., a subsidiary of Legend Capital’s co-founded company Innostellar Biotherapeutics, announced that the clinical trial application…
EC Healthcare (the Company, which together with its subsidiaries is referred to as the Group, HKG: 2138), the largest non-hospital…
As the pandemic continued to affect the market, China Biotech Services (HKG: 8037), which owns one of the largest nucleic…
SinoMab BioScience Limited (SinoMab or the Company, together with its subsidiaries, the Group, HKG: 3681), a Hong Kong-based biopharmaceutical company…
Avance Clinical, the largest premium Australian Contract Research Organisation (CRO) for international biotechs, has been selected as a finalist for…
Malaysian Genomics, airasia Super App, Speedoc and Unique Remedy Join Hands to Offer Health Solutions to airasia Super App’s 51…
EC Healthcare (the “Company”, which together with its subsidiaries is referred to as the “Group”, SEHK stock code: 2138), the…
Malaysian Genomics Resource Centre Berhad (“Malaysian Genomics” or “the Group”), a leading genomics and biopharmaceutical specialist, was recently awarded a…
On March 31, the China-based novel vaccines company – Jiangsu Recbio Technology Co., Ltd. (Recbio or the Company, HKG: 2179)…
Avance Clinical, the largest premium Australian Contract Research Organisation (CRO) for international biotechs, has opened new offices in Melbourne to…
Commercialization Driven by Innovative Platform Commitment to Create Full Reproductive Cycle Products Suzhou Basecare Medical Corporation Limited (Basecare or the…
Kingworld Medicines Group Limited (stock code: 01110.HK), a leading omni-channel enterprise providing world-famous greater health products, announced today its audited…
Genertec Universal Medical Group Company Limited (the Company or Universal Medical, and together with its subsidiaries, the Group; HKG: 2666)…
Focuses on Specialty Esoteric Testing Business Optimizes Vertical and Horizontal Industry Chain Deployment Kindstar Globalgene Technology, Inc. (Kindstar Globalgene or…
Achieves an increase of 58% in Profit-After-Tax to HK$346.0 million and Turnover Growth of 67.4% to HK$1,637.7 million Essex Bio-Technology…
Strong Performance Led by Synergistic Development of Four Main Business Lines Under One Ecosystem Sisram Medical Ltd (the Company or…
Aiming to be a leading bio-product group with green innovation and sustainability BBGI PCL (SET: BBGI), a leader in the…
SinoMab BioScience Limited (SinoMab or the Company, together with its subsidiaries, the Group, HKG: 3681), a Hong Kong-based biopharmaceutical company…